Search results for 'Zyban'
Development of VLN cigarettes for use in smoking cessation continues: 22nd Century
22nd Century Limited, LLC is pleased to announce that it is continuing development of a very low nicotine cigarette for use in smoking cessation. Clinical trial results demonstrate that these cigarettes, also referred to as ‘nicotine-free’ and ‘denicotinized,’ may be more effective for quitting than FDA-approved therapies.
http://www.news-medical.net/news/20091028/Development-of-VLN-cigarettes-for-use-in-smoking-cessation-continues-22nd-Century.aspx
Chantix and Zyban to get boxed warnings on serious mental health events
The U.S. Food and Drug Administration has announced that it is requiring manufacturers to put a Boxed Warning on the prescribing information for the smoking cessation drugs Chantix (varenicline) and Zyban (bupropion). The warning will highlight the risk of serious mental health events including changes in behavior, depressed mood, hostility, and suicidal thoughts when taking these drugs.
http://www.news-medical.net/news/20090701/Chantix-and-Zyban-to-get-boxed-warnings-on-serious-mental-health-events.aspx
Distinct clusters of genetic markers linked to treatment responses for smoking cessation
Scientists have identified distinct clusters of genetic markers associated with the likelihood of success or failure of two smoking cessation treatments, nicotine replacement therapy (NRT) and the medication bupropion (Zyban). This study, supported by the National Institute on Drug Abuse (NIDA) and the National Cancer Institute (NCI), part of the National Institutes of Health (NIH), was published in the June issue of the journal Archives of General Psychiatry.
http://www.news-medical.net/news/2008/06/02/38829.aspx
When your antidepressants don't work
should you switch to a different medication from the same class or should you try an antidepressant medication that has a different mechanism of action?
http://www.news-medical.net/news/2008/03/26/36700.aspx
Link between genetic variant and effectiveness of smoking cessation meds
A genetic variant present in nearly half of Americans of European ancestry is linked to greater effectiveness of the smoking cessation medication bupropion (Zyban), according to research by scientists supported by the National Institute on Drug Abuse (NIDA) and the National Cancer Institute (NCI), part of the National Institutes of Health (NIH).
http://www.news-medical.net/news/2007/09/11/29685.aspx
Who's still smoking?
Quitting smoking is not easy, but thousands of New Yorkers succeed at it every year. Who's trying to kick the habit, and who's succeeding? In a new report titled Who's Still Smoking?, the Health Department sheds light on both questions.
http://www.news-medical.net/news/2007/08/22/28966.aspx
FDA - all antidepressants need new warning labels
The Food and Drug Administration (FDA) in the United States wants the manufacturers of antidepressant medications to change the labels on their products.
http://www.news-medical.net/news/2007/05/03/24647.aspx
Chantix versus Zyban
Researchers in the United States say smokers who fail to quit smoking by using pills, should not be disheartened and should try again.
http://www.news-medical.net/news/2007/02/25/22166.aspx
Chantix new quit smoking drug approved
The U.S. Food and Drug Administration (FDA) has given approval for the sale of the first smoking cessation drug in almost ten years.
http://www.news-medical.net/news/2006/05/11/17915.aspx
Varenicline could increase number who quit smoking
Smokers who try to quit using existing medications, such as nicotine patches or Zyban, are about twice as likely to succeed as those who don't use medication or are prescribed placebos during clinical trials.
http://www.news-medical.net/news/2006/05/03/17723.aspx
Psychiatric patients who smoke
An editorial in the January 2006 issue of the Psychiatric Bulletin reviews the evidence for the effectiveness of gene-based smoking cessation packages, and asks whether they are appropriate for psychiatric patients.
http://www.news-medical.net/news/2006/01/10/15322.aspx
Killer secondhand smoke campaign flares up in the UK
According to new research by the National Health Service (NHS), 60 per cent of smokers light up and smoke without asking for permission, despite the fact that most non-smokers mind if other people are smoking nearby.
http://www.news-medical.net/news/2005/09/06/13014.aspx
Genetic makeup may detemine likely success of quit smoking therapies
A study by researchers at the Transdisciplinary Tobacco Use Research Center (TTURC) of the University of Pennsylvania School of Medicine indicates that a smoker's genetic make-up may affect whether they quit or not while using either bupropion (Zyban) or nicotine replacement therapies (NRTs) such as the nicotine patch or nasal spray.
http://www.news-medical.net/news/2005/08/30/12802.aspx
Few smokers make use of the help that is available
Antidepressant medicines, nicotine replacement products, and counseling can all help a smoker stick with that New Year's resolution to kick the habit. But a study by American Cancer Society researchers finds that few smokers make use of the help that is available.
http://www.news-medical.net/news/2005/01/17/7340.aspx
News-Medical.Net provides this medical information service in accordance
with these
terms and conditions.
Please note that medical information found
on this website is designed to support, not to replace the relationship
between patient and physician/doctor and the medical advice they may provide.
Subscribe